SCHEMBL2583875

SCHEMBL2583875

FN(F)C(F)(F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL393587 0.75 LMNA (0.30)
SCHEMBL1639069 0.75
SCHEMBL3945384 0.73
SCHEMBL394486 0.72 LMNA (0.35)
SCHEMBL394686 0.70 LMNA (0.40)
SCHEMBL4359264 0.70 LMNA (0.40)
SCHEMBL397273 0.70 LMNA (0.40)
SCHEMBL344485 0.70 LMNA (0.40)
SCHEMBL394883 0.70 LMNA (0.40)
SCHEMBL899793 0.70 LMNA (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101568-A1 MODIFIED REPEAT UNIT FOR ENHANCED INTERACTION ENERGY AND THERMAL STABILITY OF HIGH TEMPERATURE LUBRICANTS FOR MAGNETIC MEDIA WESTERN DIGITAL TECHNOLOGIES, INC. (US) 2026-05-15 WO claimed
US-20260125611-A1 MODIFIED REPEAT UNIT FOR ENHANCED INTERACTION ENERGY AND THERMAL STABILITY OF HIGH TEMPERATURE LUBRICANTS FOR MAGNETIC MEDIA WESTERN DIGITAL TECH INC (US) 2026-05-07 US claimed
US-11786883-B2 Adsorption cooling system using metal organic frameworks LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) 2023-10-17 US claimed
US-11686508-B2 Adsorption cooling system using metal organic frameworks LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) 2023-06-27 US claimed
WO-2010033598-A2 SYSTEM AND METHOD FOR UTILIZING MICROBUBBLES AND LIPOSOMES AS VIRAL SEQUESTERING AGENTS VERUS BIOTECHNOLOGY CORPORATION (US) 2010-03-25 WO claimed
US-20100069814-A1 SYSTEM AND METHOD FOR UTILIZING MICROBUBBLES AND LIPOSOMES AS VIRAL SEQUESTERING AGENTS VERUS BIOTECHNOLOGY CORPORATION 2010-03-18 US claimed
US-20070196462-A1 Composition and method for neuromuscular blockade IMARX THERAPEUTICS, INC. (US) 2007-08-23 US claimed
WO-2007087418-A2 COMPOSITION AND METHOD FOR NEUROMUSCULAR BLOCKADE IMARX THERAPEUTICS, INC. (US) 2007-08-02 WO claimed
US-20050003977-A1 Composition for cleaning DAIKIN INDUSTRIES, LTD. (JP) 2005-01-06 US claimed
EP-1447440-A1 COMPOSITION FOR CLEANING Daikin Industries, Ltd. (JP) 2004-08-18 EP claimed
US-20020160272-A1 Process for producing a modified electrolyte and the modified electrolyte KABUSHIKI KAISHA TOYOTA CHUO (JP) 2002-10-31 US claimed
EP-0831935-A4 GASEOUS ULTRASOUND CONTRAST AGENTS AND METHOD THEREFOR MALLINCKRODT MEDICAL INC (US) 2001-08-29 EP claimed
US-6071495-A TEMPERATURE ACTIVATED; PARTICULARLY USEFUL, FOR EXAMPLE, IN ULTRASONIC IMAGING APPLICATIONS AND IN THERAPEUTIC DRUG DELIVERY SYSTEMS. IMARX PHARMACEUTICAL CORP. (US) 2000-06-06 US claimed
US-6013243-A Gaseous inhalable ultrasound contrast agents and method therefor MALLINCKRODT INC. (US) 2000-01-11 US claimed
EP-0831935-A1 GASEOUS ULTRASOUND CONTRAST AGENTS AND METHOD THEREFOR MALLINCKRODT MEDICAL, INC. (US) 1998-04-01 EP claimed
EP-0740528-A4 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP (US) 1998-04-01 EP claimed
US-5733572-A Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles IMARX PHARMACEUTICAL CORP. (US) 1998-03-31 US claimed
WO-1996040288-A1 GASEOUS ULTRASOUND CONTRAST AGENTS AND METHOD THEREFOR MALLINCKRODT MEDICAL, INC. (US) 1996-12-19 WO claimed
EP-0740528-A1 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP. (US) 1996-11-06 EP claimed
WO-1995015118-A1 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP. (US) 1995-06-08 WO claimed